1.
Rojas Melo LJ, Ojeda Rodríguez KH, Kerguelen Villadiego AL, Parra Prieto DA. Hypophysitis and secondary adrenal insufficiency associated with Pembrolizumab. Rev.ACE [Internet]. 2022 Feb. 7 [cited 2024 Jul. 16];8(4). Available from: https://revistaendocrino.org/index.php/rcedm/article/view/726